MisOpRostol Effect on Second Trimester Abortion Blood Loss (MORESTABL)
Misoprostol Effect on Second Trimester Abortion Blood Loss
Sponsor: Stanford University
Terminated
Recruitment not feasible for this patient population within study timeframe
Other terminated trials from Stanford University
Other Blood Loss, Surgical trials with similar outcome
This PHASE3 trial investigates Blood Loss, Surgical and Second Trimester Abortion and is currently terminated or withdrawn. Stanford University leads this study, which shows 6 recorded versions since 2024 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
6 versions recorded-
Sep 2025 — Present [monthly]
Terminated PHASE3
Status: Enrolling By Invitation → Terminated
-
Sep 2024 — Sep 2025 [monthly]
Enrolling By Invitation PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Enrolling By Invitation PHASE3
-
Mar 2024 — Jul 2024 [monthly]
Enrolling By Invitation PHASE3
Status: Not Yet Recruiting → Enrolling By Invitation
-
Feb 2024 — Mar 2024 [monthly]
Not Yet Recruiting PHASE3
▶ Show 1 earlier version
-
Nov 2023 — Feb 2024 [monthly]
Not Yet Recruiting PHASE3
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Stanford University
For direct contact, visit the study record on ClinicalTrials.gov .